Fulvether 250 Injection
Marketer
Therdose Pharma Pvt Ltd
Salt Composition
Fulvestrant (250mg)
Overview Fulvether 250 Injection
Letrozole 250mg Injection is a medication that inhibits estrogen. It's indicated for treating breast cancer in postmenopausal women. Its mechanism involves regulating estrogen levels to curb cancer cell proliferation. Administered intramuscularly by a healthcare professional, the dosage and frequency are individualized based on the patient's condition and determined by their physician. Treatment duration follows the physician's prescription. Common adverse effects include injection site reactions, headache, nausea, vomiting, and allergic responses. Any concerning or persistent side effects should be reported immediately. Strategies to mitigate side effects may be available. Prior to initiating treatment, inform your doctor of any pre-existing kidney or liver conditions, bleeding disorders, use of anticoagulants, and all other medications being taken, as interactions may affect Letrozole's efficacy or mechanism. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Fulvether 250 Injection
Malignant breast tumor
Major Benefits of Fulvether 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Fulvether 250 Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulvether 250 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Fulvether 250 Injection works:
Fulvestrant 250mg injection inhibits estrogen's effects on breast cancer cells, potentially halting or reducing the growth of estrogen-receptor-positive tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol alongside Fulvether 250 Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Fulvether 250 Injection to pregnant individuals poses a confirmed risk to the fetus. Its use during pregnancy is therefore contraindicated except in potentially life-threatening circumstances where the physician deems the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Fulvether 250 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Fulvether 250 Injection.
KidneyCAUTION
Exercise caution when administering Fulvether 250 Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Fulvether 250 Injection use in such patients is limited. Dosage alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Individuals with hepatic impairment should use Fulvether 250 Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulvether 250 Injection :
Should you forget a scheduled Fulvether 250 Injection, seek medical advice.
Facts to Know About Fulvether 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Estrogen Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Estrogen receptor blocker |
3,018 People bought this recently